[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"drug-induced-diabetes\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:drug-induced-diabetes":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":29,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":49},"100612375","nutritional-management-of-the-patient-with-type-2-diabetes-at-nutritional-risk-or-with-malnutrition-in-clinical-practice-100612375",false,"NCT07252765","Nutritional Management of the Patient With Type 2 Diabetes at Nutritional Risk or With Malnutrition in Clinical Practice","Nutritional Management of the Patient With Type 2 Diabetes at Nutritional Risk or With Malnutrition in Clinical Practice. STARLIGHT Study","STARLIGHT","Inclusion Criteria:\n\n* Adult patients diagnosed with type 2 diabetes (T2D) or drug-induced diabetes\n* Patients at nutritional risk according to MUST or presenting malnutrition according to GLIM criteria.\n* Patients requiring a diabetes-specific oral nutritional supplement (ONS) that is high-calorie, high-protein, and contains soluble fiber in real-world clinical practice, and who have been prescribed such a supplement within the previous 7 days.\n* Patients able to provide informed consent and complete the study questionnaires.\n\nExclusion Criteria:\n\n* Patients participating in other studies or clinical trials related to malnutrition, or who, in the investigator's opinion, may alter the course of the study.\n* Patients currently receiving or expected to receive other types of nutritional interventions involving supplements (oral or otherwise) or non-conventional feeding methods (e.g., feeding tubes).\n* Patients with a history of metabolic\u002Fendocrine diseases (other than diabetes) or any other condition causing liver or kidney failure, defined as ALT \\> 3x ULN or eGFR \\\u003C 30 ml\u002Fmin\u002F1.73 m², and according to the investigator's judgment.\n* Patients expected to undergo any surgical intervention or require hospitalization due to a condition unrelated to the study during the study period.\n* Patients with other conditions that, in the investigator's opinion, may interfere with adherence to the intervention or with study procedures.","ALL","18 Years",{"count":20,"type":21},334,"ESTIMATED","OBSERVATIONAL","The objective of this observational study is to characterize the patient profile and nutritional treatment patterns of individuals with type 2 diabetes (T2D) or drug-induced diabetes who present with malnutrition, or are at risk of it, and who are prescribed a diabetes-specific oral nutritional supplement (ONS) that is high in calories and protein and contains soluble fiber.\n\nParticipants will complete a series of questionnaires during visits 1 and 3.",[25,26,27,28],"Type 2 Diabetes Mellitus (T2DM)","Malnutrition","Malnourishment","Drug-Induced Diabetes",[30,31,32,33,34,35,27,26,36],"Metabolic control","Disease - realted malnutrition","Diabetes-specific formula","T2D","Oral nutritional supplementation","Type 2 Diabetes Mellitus","Drug-induced diabetes","RECRUITING","2026-01-26",{"date":40,"type":41},"2026-01-28","ACTUAL",{"date":43,"type":41},"2025-11-20",{"date":45,"type":21},"2026-10",{"name":47,"class":48},"Outcomes'10","NETWORK",12]